We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Reagents for GeneChip Expression Array

By Biotechdaily staff writers
Posted on 12 Feb 2004
A new line of GeneChip expression reagents has been developed, offering a complete, standardized sample preparation system that is easier to use and will help customers produce more robust and consistent array results, whether used for diagnostic biopsies or bioresearch.

The reagents were developed for use with the GeneChip IVT Labeling Kit of Affymetrix (Santa Clara, CA, USA) in collaboration with Invitrogen Corp. (Carlsbad, CA, USA). The reagents include two new complementary DNA (cDNA) synthesis kits that contain Invitrogen's SuperScript reverse transcriptase (RT). The One-Cycle cDNA synthesis kit offers all necessary reagents for standard target labeling, using as little as 1 ug of total RNA as starting material prior to the labeling step. The Two-Cycle cDNA kit offers customers a streamlined procedure for preparing samples using a small amount of material, such as biopsy or laser capture dissected samples. The entire procedure takes only two and a half days, compared to four days with the previous procedure.

The new GeneChip IVT Labeling Kit was developed specifically for the GeneChip platform to provide high-yield, consistent, and uniform labeling efficiency, with more streamlined protocol and convenient packaging.




Related Links:
Affymetrix
Invitrogen

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
12 Feb 2004  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
12 Feb 2004  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
12 Feb 2004  |   BioResearch